Approval · Notice of Compliance 5350 · 2004
TRASYLOL: Notice of Compliance 5350
Issued September 17, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5350
- Date
- September 17, 2004
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Polypeptide proteinase inhibitor / hemostatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRASYLOL | 02186845 | Dormant |
Medicinal ingredients
- APROTININ 10,000 UNIT per ML